An observational study in Microbial Colonization and Scalp--Diseases, sponsored by Indonesia University. Completed at 1 site in Indonesia. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-04.
Sponsored by Indonesia University · Observational
An observational study was performed on 48 women wearing hijab and 48 women not wearing hijab to compare the scalp microbiome.
The scalp sample of all subjects was taken to be analyzed for its microbial diversity. The samples were processed with Next-Generation Sequencer and analyzed with bioinformatics analysis.
The primary outcome was the characteristics of scalp microbiome
4,451 studies on the registry are indexed under Communicable Diseases; 521 are open to participants now.
This study's enrollment of 96 is below the median of 244 across 1,499 observational studies indexed under Communicable Diseases.
Browse Communicable Diseases studies →Indonesia University is the lead sponsor of 448 studies on the registry; 56 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Healthy women aged 18 years old or older who had not undergone menopause
Exclusion Criteria:
Women wearing hijab whose scalp sample was taken for microbiome analysis
Procedure: Swab
Women not wearing hijab whose scalp sample was taken for microbiome analysis
Procedure: Swab
The scalp was swabbed with five strokes which were performed each in a vertical, horizontal, left diagonal, and right diagonal direction. The swab was moved back and forth for 10 times
Alpha diversity and beta diversity of scalp microbiome
The alpha and beta diversity of scalp microbiome which is generated by bioinformatics analysis from the sample processed with Next-Generation Sequencing
Time frame: Up to 2 years
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Indonesia University